Charles E. Bugg
Overview
Charles E. Bugg received an average of $598K in total compensation, including $312K in salary, at BioCryst Pharmaceuticals between 2006 and 2007.
Source: SEC filing on April 16, 2008.
Related executives
We found 16 more executives who work or worked at BioCryst Pharmaceuticals.
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
Helen Thackray
BioCryst Pharmaceuticals
Chief R&D Officer
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
Yarlagadda Babu
BioCryst Pharmaceuticals
Chief Discovery Officer
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
Lynne Powell
BioCryst Pharmaceuticals